Siri Margrete Hugo Lohne, Hanna Hebelka, Jip Frederik Prince, Anneloes Elisabeth Bohte, Annemieke Simone Littooij, Charlotte de Lange, Annamaria Deganello, Silvia Costa Dias, Greg Chambers, Seema Toso, Céline Habre, Erika Pace, Stéphanie Franchi-Abella, Helen Woodley, Simon P McGuirk
{"title":"Challenges with the PRETEXT staging system: a SIOPEL Radiology Group position paper.","authors":"Siri Margrete Hugo Lohne, Hanna Hebelka, Jip Frederik Prince, Anneloes Elisabeth Bohte, Annemieke Simone Littooij, Charlotte de Lange, Annamaria Deganello, Silvia Costa Dias, Greg Chambers, Seema Toso, Céline Habre, Erika Pace, Stéphanie Franchi-Abella, Helen Woodley, Simon P McGuirk","doi":"10.1007/s00247-026-06786-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The PRETreatment EXTent of disease (PRETEXT) staging system is widely used in malignant pediatric liver tumors; however, significant challenges associated with this system remain.</p><p><strong>Objective: </strong>To describe challenges and limitations of the current PRETEXT system and propose potential strategies to mitigate them, from the European (SIOPEL) perspective.</p><p><strong>Methods: </strong>Expert insights from the SIOPEL Radiology Group, derived from both clinical and research experience, have been integrated into a position paper.</p><p><strong>Results: </strong>Key limitations include acquisition and inter-observer variability, definitional ambiguity for PRETEXT group and annotation factors, lack of structured reporting, gaps in surgical integration, and POST-Treatment EXTent of disease (POSTTEXT)-related pitfalls. Proposed strategies to address PRETEXT challenges include broader implementation of standardized imaging protocols and structured reporting, multidisciplinary integration, central review, definition refinement, and emerging technologies.</p><p><strong>Conclusion: </strong>Addressing these challenges may improve diagnostic accuracy, risk stratification, and clinical decision-making in pediatric patients with malignant liver tumors.</p>","PeriodicalId":19755,"journal":{"name":"Pediatric Radiology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00247-026-06786-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The PRETreatment EXTent of disease (PRETEXT) staging system is widely used in malignant pediatric liver tumors; however, significant challenges associated with this system remain.
Objective: To describe challenges and limitations of the current PRETEXT system and propose potential strategies to mitigate them, from the European (SIOPEL) perspective.
Methods: Expert insights from the SIOPEL Radiology Group, derived from both clinical and research experience, have been integrated into a position paper.
Results: Key limitations include acquisition and inter-observer variability, definitional ambiguity for PRETEXT group and annotation factors, lack of structured reporting, gaps in surgical integration, and POST-Treatment EXTent of disease (POSTTEXT)-related pitfalls. Proposed strategies to address PRETEXT challenges include broader implementation of standardized imaging protocols and structured reporting, multidisciplinary integration, central review, definition refinement, and emerging technologies.
Conclusion: Addressing these challenges may improve diagnostic accuracy, risk stratification, and clinical decision-making in pediatric patients with malignant liver tumors.
期刊介绍:
Official Journal of the European Society of Pediatric Radiology, the Society for Pediatric Radiology and the Asian and Oceanic Society for Pediatric Radiology
Pediatric Radiology informs its readers of new findings and progress in all areas of pediatric imaging and in related fields. This is achieved by a blend of original papers, complemented by reviews that set out the present state of knowledge in a particular area of the specialty or summarize specific topics in which discussion has led to clear conclusions. Advances in technology, methodology, apparatus and auxiliary equipment are presented, and modifications of standard techniques are described.
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.